NCT04512846

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Large Hepatocellular Carcinoma (5-10 cm) With or Without Transcatheter Arterial Chemoembolization (TACE)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Beijing 302 Hospital · Academic / Other
• Sex: All
• Age: 30 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The study aims to compare efficacy and adverse reactions of large hepatocellular carcinoma participants (5-10cm) who receive stereotactic body radiation therapy with or without transcatheter arterial chemoembolization.The investigators will optimize the combined treatment schedule of SBRT for hepatocellular carcinoma participants by comparing overall survival rates, progression-free survival rates and local control and adverse reaction occurrence rates in the two groups.

Conditions

• Large HCC Patients
• Stereotactic Body Radiation Therapy
• Transcatheter Arterial Chemoembolization

Timeline

• Start date: 2020-08-01
• Primary completion: 2023-08-01
• Completion: 2026-08-30
• First posted: 2020-08-14
• Last updated: 2023-06-27

Locations

1 site across 1 country: China